Hand, foot, and mouth disease (HFMD) pathogen detection is the laboratory process of identifying causative enteroviruses—primarily Enterovirus A71 (EV-A71) and Coxsackievirus A16 (CV-A16)—in clinical specimens using molecular, serological, and culture-based methods. Accurate and timely pathogen identification supports early diagnosis, differential diagnosis, severe-case risk stratification, and public health surveillance. This article provides a comprehensive technical overview of HFMD pathogen detection, covering specimen types, testing items, analytical methods, quality requirements, and typical applications.
Technical Overview
Hand, foot, and mouth disease (HFMD) is a common infectious disease that predominantly affects children under five years of age, characterized by fever, vesicular lesions on the hands, feet, and mouth, and herpangina. The disease is caused by enteroviruses belonging to the family Picornaviridae, genus Enterovirus, with Enterovirus A71 (EV-A71) and Coxsackievirus A16 (CV-A16) historically responsible for the majority of cases. In recent years, Coxsackievirus A6 (CV-A6) and Coxsackievirus A10 (CV-A10) have also emerged as significant pathogens associated with atypical and widespread skin manifestations.
Transmission occurs mainly through the fecal-oral route, respiratory droplets, and direct contact with vesicular fluid or contaminated surfaces. Although most infections are self-limiting, EV-A71 in particular can progress to severe neurological complications such as aseptic meningitis, brainstem encephalitis, acute flaccid paralysis, and neurogenic pulmonary edema. Because clinical presentation alone cannot reliably distinguish the causative serotype or predict disease severity, laboratory-based pathogen detection is a critical component of HFMD management, epidemiological surveillance, and outbreak control. Accordion to diagnostic criteria such as WS/T 288 and quality frameworks including ISO 15189, laboratory confirmation plays a decisive role in clinical decision-making and public health response.
Testing Samples
Appropriate specimen selection directly affects detection sensitivity. Different specimen types have distinct viral shedding profiles across the course of illness, and multiple specimen types may be collected in parallel to maximize diagnostic yield.
Throat Swabs and Nasopharyngeal Swabs
Throat swabs are the most commonly used specimens for molecular testing during the acute phase. Viral RNA is generally detectable in throat specimens within the first week of symptom onset, making them suitable for rapid real-time RT-PCR screening. Specimens should be collected using flocked or synthetic fiber swabs and placed immediately into viral transport medium.
Stool Specimens and Rectal Swabs
Enteroviruses replicate in the intestinal tract and are shed in feces for up to several weeks after symptom resolution. Stool and rectal swabs therefore provide the highest and most prolonged viral loads, and are particularly valuable when patients present late in the course of illness or during epidemiological investigations.
Vesicle Fluid
Fluid aspirated from cutaneous or oral vesicles typically contains a high concentration of viral particles and offers strong specificity, since the lesion is the direct site of viral replication. Vesicle fluid collection is recommended whenever characteristic lesions are present and is especially useful for confirming atypical cases.
Cerebrospinal Fluid (CSF)
For patients presenting with neurological complications such as meningitis, encephalitis, or acute flaccid paralysis, CSF should be collected and tested to support etiological diagnosis of severe HFMD. A positive CSF result provides direct evidence of central nervous system involvement and carries significant prognostic importance.
Blood and Serum
Serum specimens are used primarily for serological assays, including IgM capture ELISA and neutralizing antibody testing, as well as for molecular testing in severe cases where viremia may be detectable. Paired acute- and convalescent-phase sera can demonstrate seroconversion for retrospective diagnosis.
All specimens should be transported in viral transport medium under cold chain conditions at 2–8°C and tested as soon as possible. If testing is delayed, specimens should be frozen at −70°C or below to preserve viral RNA integrity, in accordance with laboratory biosafety requirements such as ISO 15190 and GB 19489.
Testing Items
HFMD pathogen detection panels are typically structured as a tiered workflow covering the following items:
- Pan-enterovirus universal screening targeting conserved regions of the 5' untranslated region (5'UTR) of the enterovirus genome
- EV-A71-specific RNA detection targeting the VP1 or VP2 capsid region
- CV-A16-specific RNA detection targeting the VP1 region
- CV-A6, CV-A10, and other less common serotype identification for atypical or severe cases
- Virus isolation and serotype confirmation by culture-based methods
- Serological testing, including enterovirus-specific IgM antibody and neutralizing antibodies against EV-A71 and CV-A16
- Molecular typing and phylogenetic analysis based on VP1 sequencing for epidemiological investigation
- Metagenomic next-generation sequencing for complex, severe, or diagnostically unresolved cases
Testing Methods
Real-Time Fluorescent RT-PCR
Real-time fluorescent reverse transcription polymerase chain reaction (RT-PCR) is the primary method for HFMD pathogen detection in clinical laboratories. Viral RNA is extracted from specimens, reverse-transcribed into cDNA, and amplified with serotype-specific primers and fluorescent hydrolysis probes. This approach offers high sensitivity and specificity, a short turnaround time of several hours, and quantitative capability. Most diagnostic algorithms begin with a pan-enterovirus assay, followed by EV-A71 and CV-A16 typing assays on positive specimens.
Multiplex PCR and Conventional RT-PCR
Multiplex RT-PCR assays allow the simultaneous detection and differentiation of multiple enterovirus serotypes, including EV-A71, CV-A16, CV-A6, and CV-A10, within a single reaction, improving efficiency and reducing sample consumption. Conventional RT-PCR combined with agarose gel electrophoresis remains in use in resource-limited settings and as a complementary confirmatory tool, though it is less sensitive than real-time methods and requires strict contamination control.
Virus Isolation and Cell Culture
Virus isolation is regarded as the classical reference method for enterovirus confirmation. Specimens are inoculated into susceptible cell lines such as human rhabdomyosarcoma (RD) cells, Vero cells, or human embryonic kidney cells, and observed for characteristic cytopathic effects. Isolated strains can then be identified by immunofluorescence, neutralization assays, or sequencing. Although culture is labor-intensive and requires one to two weeks, it remains indispensable for obtaining viable virus isolates used in vaccine research, antigenic analysis, and molecular epidemiology.
Serological Testing
Serological methods include IgM capture ELISA, which can indicate recent infection from a single acute-phase specimen, and the virus neutralization test, which measures serotype-specific neutralizing antibodies and serves as the gold standard for sero-epidemiological studies and vaccine immunogenicity evaluation. Serology is particularly useful when molecular specimens are unavailable or collected late, though cross-reactivity among enteroviruses and maternal antibodies in infants must be considered during interpretation.
Next-Generation Sequencing (NGS)
Metagenomic NGS enables unbiased detection of all potential pathogens in a specimen without prior knowledge of the target, making it valuable for severe, atypical, or culture- and PCR-negative cases. Targeted amplicon sequencing of the VP1 region supports precise serotype assignment and phylogenetic characterization for outbreak tracing and viral evolution studies.
Laboratories performing HFMD pathogen detection should operate under a quality management system compliant with ISO 15189, implement validated assays with appropriate internal controls, and handle specimens within biosafety level 2 facilities in accordance with ISO 15190 and applicable national biosafety regulations.
Applications
- Clinical diagnosis: laboratory confirmation of HFMD and differentiation from look-alike conditions such as herpangina, varicella, and drug eruptions
- Severe case risk stratification: early identification of EV-A71 infection to guide hospitalization, monitoring, and intervention for patients at risk of neurological complications
- Public health surveillance: systematic serotype monitoring to track dominant circulating strains and detect epidemiological shifts
- Outbreak investigation: molecular typing and phylogenetic analysis to establish transmission chains in childcare facilities, schools, and communities
- Vaccine evaluation: neutralizing antibody testing to assess EV-A71 vaccine immunogenicity, immune persistence, and breakthrough infection analysis
- Scientific research: viral isolation, genome sequencing, and antigenic characterization supporting drug development, vaccine research, and evolutionary studies
FAQ
Which specimen type provides the most reliable detection result?
Throat swabs collected during the first week of illness are most practical for rapid molecular diagnosis, while stool specimens provide the highest viral loads and the longest detection window. For patients with typical lesions, vesicle fluid offers excellent specificity, and for severe cases with neurological signs, CSF testing is essential. Collecting multiple specimen types in parallel is recommended whenever feasible.
How long after symptom onset can the virus still be detected?
Viral RNA is generally detectable in throat swabs during the first three to seven days of illness, whereas fecal shedding may persist for two to eight weeks or longer. Serological testing using IgM ELISA or paired sera can provide diagnostic evidence when specimens are collected beyond the period of optimal molecular detectability.
What does a positive pan-enterovirus result with negative EV-A71 and CV-A16 results indicate?
This pattern indicates infection by an enterovirus other than EV-A71 or CV-A16, such as CV-A6, CV-A10, or other enterovirus A serotypes. Further serotype-specific PCR or VP1 sequencing is recommended to identify the causative agent, particularly in severe or epidemiologically significant cases.
What is the difference between PCR and serological testing for HFMD?
PCR directly detects viral genetic material and is best suited for acute-phase diagnosis due to its speed, sensitivity, and serotype-differentiation capability. Serology detects the host immune response, which develops over several days, and is more useful for retrospective diagnosis, sero-epidemiological surveys, and vaccine immune response evaluation. The two approaches are complementary rather than interchangeable.
What biosafety precautions are required for HFMD specimen testing?
Enteroviruses are generally handled at biosafety level 2. Laboratories should follow requirements of ISO 15190 and national biosafety standards, including specimen processing in certified biological safety cabinets, use of appropriate personal protective equipment, validated decontamination procedures, and rigorous waste management. Virus isolation and culture activities require enhanced risk assessment and dedicated facilities.
Why is serotype identification important when most HFMD cases are mild?
Because EV-A71 is strongly associated with severe neurological disease and fatal outcomes while other serotypes typically cause milder illness, serotype identification directly informs clinical risk management, including decisions on hospital admission, intensive monitoring, and early intervention. At the population level, serotype data guide surveillance strategies and vaccine policy, since current inactivated vaccines protect against EV-A71 but not against CV-A16 or other serotypes.